Edgewise Therapeutics shares surge on positive trial results

Dec 16, 2024  · Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) experienced a notable 21% increase in premarket trading today following the announcement of successful results …


21%
OFF

Edgewise Therapeutics Shares Surge On Positive Trial Results

2 weeks from now

Dec 16, 2024  · Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) experienced a notable 21% increase in premarket trading today following the announcement of successful results …

investing.com

21%
OFF

Edgewise Therapeutics Shares Surge On Positive Trial Results

2 weeks from now

Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) experienced a notable 21% increase in premarket trading today following the announcement of successful results from its Phase 2 …

investing.com

18%
OFF

EWTX Stock Rises On Upbeat Data From Rare Muscular Disorder …

2 weeks from now

Dec 17, 2024  · Shares of Edgewise Therapeutics EWTX were up more than 18% on Monday after it announced positive results from the mid-stage CANYON study on its lead pipeline drug, …

nasdaq.com

17%
OFF

Edgewise Therapeutics Stock Soars After Positive Mid-stage Drug …

2 weeks from now

Shares of Edgewise Therapeutics (NASDAQ:EWTX) surged approximately 17% to $32.28 in premarket trading following the announcement that its experimental drug for a rare genetic …

grafa.com

50%
OFF

Edgewise Shares Jump After Positive Heart Drug Data

2 weeks from now

Sep 20, 2024  · Edgewise Therapeutics has reported positive top-line results for its HCM treatment candidate, EDG-7500, boosting shares by over 50%. Phase II trials show improved heart …

thepharmaletter.com

50%
OFF

Edgewise Therapeutics Soars 50%: Key Reasons Behind The Surge

2 weeks from now

Sep 19, 2024  · Edgewise Therapeutics NASDAQ: EWTX is up 50% in a single session and 450% from recent lows for a reason. Its novel, oral, selective treatment for obstructive hypertrophic …

marketbeat.com

21%
OFF

Edgewise Therapeutics Shares Surge On Positive Trial Results

2 weeks from now

Dec 16, 2024  · Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) experienced a notable 21% increase in premarket trading today following the announcement of successful results …

investing.com

332%
OFF

Edgewise Stock Up 332%: Analysts Believe It's Not Too Late

2 weeks from now

Sep 25, 2024  · Edgewise Therapeutics is taking the market by storm, up over 300% in 52 weeks. Its cardiovascular treatment showed positive results, sending shares up 50% in a day. The …

marketbeat.com

50%
OFF

Edgewise Therapeutics Soars 50%: Key Reasons Behind The Surge

2 weeks from now

Sep 19, 2024  · Edgewise Therapeutics has an attractive, if small, pipeline of candidates in early stage 1 and stage 2 trials. They target individuals with Duchenne and Becker muscular …

nasdaq.com

332%
OFF

Edgewise Therapeutics (NASDAQ:EWTX) Shares Up 7.4

2 weeks from now

2 days ago  · Get Our Latest Stock Report on Edgewise Therapeutics Edgewise Therapeutics Trading Up 6.7 %. Analysts Think There's Still Time to Get in on Edgewise, Up 332%; The firm …

marketbeat.com

60%
OFF

OS Therapies Shares Surge 60% After Clinical Trial Yields Positive …

2 weeks from now

1 day ago  · OS Therapies shares surged Wednesday after the biotech company reported positive data from a clinical trial for its cancer treatment OST-HER2. Shares of the N.Y., clinical-stage …

marketwatch.com

$1.50
OFF

Edgewise Therapeutics (EWTX) Earnings Date And Reports 2025

2 weeks from now

6 days ago  · With a trailing EPS of -$1.50, Edgewise Therapeutics' earnings are expected to decrease next year, from ($1.45) to ($1.79) per share. EWTX Upcoming Earnings Edgewise …

marketbeat.com

FAQs about Edgewise Therapeutics shares surge on positive trial results Coupon?

Who is Edgewise Therapeutics?

More about Edgewise Therapeutics Edgewise Therapeutics is a leading biopharmaceutical company in the muscle disease industry, focused on developing treatments for muscular dystrophies. The company’s primary product is sevasemten, an orally administered fast skeletal myosin inhibitor aimed at protecting muscle against contraction-induced damage. ...

Will Edgewise rise after early trial results for heart disease therapy?

Edgewise Therapeutics, Inc. (EWTX) Stock has risen after early trial results for heart disease therapy, as reported on Sep. 19, 2024. ...

Why did OS therapies stock surge Wednesday?

By Owen Tucker-Smith OS Therapies shares surged Wednesday after the biotech company reported positive data from a clinical trial for its cancer treatment OST-HER2. Shares of the N.Y., clinical-stage biotechnology company were recently up 60% to $6.64 in premarket trading, which is above the stock's 52-week high of $6.48. ...

Install CouponFollow Extension on Chrome

Install the CouponFollow extension to search for discount codes when shopping the fastest!

Install CouponFollow Chrome Extension   Install CouponFollow Chrome Extension